The abstract is read at the publisher; the summary is JClub's.
In a nationwide registry of 2,524 Chinese patients with distal medium vessel occlusion stroke, EVT plus SMT increased 90-day freedom from disability (aRR 1.15) but raised sICH risk (aRR 4.03).
- Why it matters: Evidence for endovascular treatment in acute ischemic stroke due to distal medium vessel occlusion is uncertain, especially regarding whether benefits outweigh hemorrhage risks.
- What they did: From 2023–2025 across 116 sites in China, investigators compared EVT plus standard medical treatment versus standard medical treatment alone within 24 hours, using inverse probability of treatment weighting.
- The result: EVT plus SMT improved 90-day disability freedom by an adjusted risk difference of 4.36% (95% CI 1.73%-6.99%), increased symptomatic intracranial hemorrhage, and showed no significant difference in 90-day mortality (aRR 0.97).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.